Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Trading Update

5 Nov 2014 09:48

RNS Number : 2048W
Symphony Environmental Tech. PLC
05 November 2014
 

 

 

 

Press Release

5th November 2014

 

 

 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony" "Group" or the "Company")

 

 

SANAFORTM PO-5 - US EPA REGISTRATION & D2P UPDATES

 

LAUNCH OF DURABLE ANTI-MICROBIAL SHOPPING BAG

 

Symphony Environmental Technologies Plc (AIM: SYM), global specialists in "making plastic smarter", with d2w biodegradable, d2p anti-microbial and d2t anti-counterfeiting technologies, is pleased to announce the registration of SANAFORTM PO-5 by the U.S. Environmental Protection Agency (EPA), and also the further expansion of Symphony's d2p product range.

 

SANAFORTM PO-5

 

The SANAFORTM PO-5 masterbatch is part of Symphony's d2p anti-microbial product range and is marketed under a Distributorship Agreement between Symphony and Janssen PMP (a Division of Janssen Pharmaceutica NV).

 

SANAFORTM antimicrobial technology, was developed by Janssen PMP (as experts in anti-microbial formulations) and introduced into plastics by Symphony (as experts in plastics). SANAFORTM antimicrobial technology is included in the production process for plastic products for the automotive, industrial, healthcare, catering, textiles, footwear and home and leisure sectors - from building materials and appliances to food storage containers and chopping boards, toilet seats, and many other applications where anti-microbial protection is needed. It is easily added during manufacture and has no impact on the strength or durability of the plastic.

 

Symphony's d2p anti-microbial range of Masterbatches and Additives has been developed to resolve the issues relating to most types of bacteria whether gram positive or negative. These d2p technologies have also been proven effective against algae, mould, mildew, yeast and some viral strains in a diverse range of product applications. These include many different types of plastic resins, paint, rubber and silicone, in addition to liquid formulations that are presently being trialled in post-harvest applications for fruit and vegetables.

 

The d2p family also includes a suite of insecticide masterbatches for uses mainly in the tropics for protection against mosquitoes and other dangerous insects.

 

BAG FOR LIFE

This week Symphony launched the world's first anti-microbial bag for life with SANAFORTM antimicrobial technology inside, as shoppers are being forced by legislation to buy thicker bags and to reuse the bag over and over again. In practice, these bags are rarely cleaned or disinfected inside, and SANAFORTM antimicrobial technology can improve surface hygiene and to help prevent the build-up of germs.

 

Our mission is to create value in both the healthcare and food and retail sectors.

 

Further information on the Symphony Group can be found at www.symphonyenvironmental.com.

 

- Ends -

 

Contacts

Symphony Environmental Technologies Plc

 

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, FD

 

 

Cantor Fitzgerald Europe

 

Mark Percy / David Foreman (Corporate Finance)

Tel: +44 (0) 20 7894 7000

David Banks / Paul Jewell (Corporate Broking)

 

 

About Symphony Environmental Technologies plc

 

In addition to the d2p technology described above Symphony has developed oxo-biodegradable technology which turns plastic at the end of its service-life into materials with a completely different molecular structure. It is then no longer a plastic and can be bioassimilated in the open environment in the same way as a leaf. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world. In some countries oxo-biodegradable plastic is mandatory. For a video of d2w® plastic degrading see http://degradable.net/play-videos/4.

 

In addition Symphony has developed the d2Detector®, a portable device which analyses plastics and detects counterfeit products. Symphony's d2t tagging and tracer technology is also available for further security. See www.d2t.net

 

In addition, Symphony Recycling Technologies ("SRT") is developing innovative and cost-effective recycling systems to convert scrap tyres and other waste-streams into valuable products (http://symphonyrecycling.net )

 

Symphony has a diverse and growing customer-base and has established itself as an international business with 74 distributors around the world. Products made with Symphony's plastic technologies are now available in 97countries and in many different product applications. Symphony is certified to ISO9001 and ISO14001.

 

Symphony is a member of The Oxo-biodegradable Plastics Association (www.biodeg.org) (OPA), the Society for the Chemical Industry (UK), and the Pacific Basin Environmental Council. Symphony actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Symphony Group can be found at www.symphonyenvironmental.com.

 

About Janssen PMP

Janssen PMP is a division of Janssen Pharmaceutica NV. Janssen is one of the most innovative pharmaceutical companies in the world with more than 40,000 employees.

Janssen PMP has more than 30 years of experience in the development and commercialization of sustainable products that are used to preserve and protect materials against biological degradation.

 

Further information on the SANAFORTM antimicrobial technology can be found at: www.sanafor.info

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLIFSALTLEIIS
Date   Source Headline
28th Dec 200711:06 amRNSResult of EGM
21st Dec 20073:38 pmRNSHolding(s) in Company
19th Dec 200712:41 pmRNSHolding(s) in Company
12th Dec 20074:09 pmRNSHolding(s) in Company
11th Dec 20073:25 pmRNSIssue of Equity
10th Dec 20074:34 pmRNSHolding(s) in Company-Replace
5th Dec 20074:58 pmRNSHolding(s) in Company
4th Dec 20077:01 amRNSIssue of Equity & EGM Notice
3rd Dec 20074:48 pmRNSIssue of Equity & EGM Notice
26th Nov 20073:29 pmRNSTotal Voting Rights
26th Nov 200711:20 amRNSIssue of Options
2nd Oct 20074:16 pmRNSChange of Adviser
28th Sep 20073:50 pmRNSAdditional Listing - Amended
27th Sep 20078:00 amRNSAdditional Listing
27th Sep 20077:01 amRNSInterim Results
17th Aug 20073:37 pmRNSAIM Rule 26
3rd Aug 20077:01 amRNSAppointment of Director
27th Jul 20079:38 amRNSAGM resolutions
27th Jul 20079:00 amRNSAGM Statement
18th Jul 20077:00 amRNSTrading on PLUS
29th Jun 20077:00 amRNSReport & Accounts/AGM Notice
28th Jun 20077:01 amRNS2007 Preliminary Results
30th May 20071:40 pmRNSBusiness Update
9th May 20072:02 pmRNSAdditional Listing
30th Apr 20074:37 pmRNSBus Update & Board Change
7th Mar 20073:59 pmRNSHolding(s) in Company
2nd Mar 200710:51 amRNSHolding(s) in Company
28th Feb 20077:03 amRNSUpdate on placing
27th Feb 20079:57 amRNSResult of EGM
22nd Feb 200710:01 amRNSTrading Update
6th Feb 20077:00 amRNSNotice of EGM
19th Dec 200611:02 amRNSTotal Voting Rights
15th Dec 20067:58 amRNSTrading Statement
13th Nov 20062:16 pmRNSBoard Appointment
13th Oct 20069:28 amRNSTrading Update
25th Sep 20067:01 amRNSInterim Results
20th Sep 200611:07 amRNSNotice of Results
29th Aug 20068:59 amRNSDirectorate Change
21st Aug 20067:00 amRNSSales Agreement
14th Jul 200611:54 amRNSResult of AGM
14th Jul 20069:49 amRNSAGM Statement
21st Jun 200610:04 amRNSNotice of AGM
15th Jun 20067:02 amRNSStrategic Update
22nd May 20067:00 amRNSCaribbean Sales Update
27th Apr 20067:00 amRNSPreliminary Results
24th Apr 20067:01 amRNSNotice of Results (Revised)
4th Apr 20062:12 pmRNSNotice of Results
30th Jan 200611:41 amRNSCourt Award
16th Jan 20068:44 amRNSDirector Shareholding
19th Dec 20053:26 pmRNSCourt Victory

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.